Global Oligonucleotides Market Growth (Status and Outlook) 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Oligonucleotides market size is predicted to grow from US$ 1485 million in 2025 to US$ 2700 million in 2031; it is expected to grow at a CAGR of 10.5% from 2025 to 2031.
Oligonucleotides are short nucleic acid polymers used in research, genetic testing and forensics.
Oligonucleotides are usually made up of 13 to 25 nucleotides and are designed to hybridize specifically to DNA or RNA sequences. Solid-phase clinical synthesis is used to manufacture these small bits of nucleic acid for use in polymerase chain reaction (PCR), DNA sequencing, library construction and artificial gene synthesis.
Global Oligonucleotides key players include Integrated DNA Technologies, Agilent, Sigma-aldrich, Eurofins Genomics, L.G.C Biosearch Technologies, etc. Global top five manufacturers hold a share over 45%.
North America is the largest market, with a share over 35%, followed by Europe and China, both have a share over 35percent.
In terms of product, DNA Oligos is the largest segment, with a share over 65%. And in terms of application, the largest application is Research, followed by Pharmaceutical.
LPI (LP Information)' newest research report, the “Oligonucleotides Industry Forecast” looks at past sales and reviews total world Oligonucleotides sales in 2024, providing a comprehensive analysis by region and market sector of projected Oligonucleotides sales for 2025 through 2031. With Oligonucleotides sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Oligonucleotides industry.
This Insight Report provides a comprehensive analysis of the global Oligonucleotides landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Oligonucleotides portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Oligonucleotides market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Oligonucleotides and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Oligonucleotides.
This report presents a comprehensive overview, market shares, and growth opportunities of Oligonucleotides market by product type, application, key players and key regions and countries.
Segmentation by Type:
The global Oligonucleotides market size is predicted to grow from US$ 1485 million in 2025 to US$ 2700 million in 2031; it is expected to grow at a CAGR of 10.5% from 2025 to 2031.
Oligonucleotides are short nucleic acid polymers used in research, genetic testing and forensics.
Oligonucleotides are usually made up of 13 to 25 nucleotides and are designed to hybridize specifically to DNA or RNA sequences. Solid-phase clinical synthesis is used to manufacture these small bits of nucleic acid for use in polymerase chain reaction (PCR), DNA sequencing, library construction and artificial gene synthesis.
Global Oligonucleotides key players include Integrated DNA Technologies, Agilent, Sigma-aldrich, Eurofins Genomics, L.G.C Biosearch Technologies, etc. Global top five manufacturers hold a share over 45%.
North America is the largest market, with a share over 35%, followed by Europe and China, both have a share over 35percent.
In terms of product, DNA Oligos is the largest segment, with a share over 65%. And in terms of application, the largest application is Research, followed by Pharmaceutical.
LPI (LP Information)' newest research report, the “Oligonucleotides Industry Forecast” looks at past sales and reviews total world Oligonucleotides sales in 2024, providing a comprehensive analysis by region and market sector of projected Oligonucleotides sales for 2025 through 2031. With Oligonucleotides sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Oligonucleotides industry.
This Insight Report provides a comprehensive analysis of the global Oligonucleotides landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Oligonucleotides portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Oligonucleotides market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Oligonucleotides and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Oligonucleotides.
This report presents a comprehensive overview, market shares, and growth opportunities of Oligonucleotides market by product type, application, key players and key regions and countries.
Segmentation by Type:
- DNA Oligos
- RNA Oligos
- Pharmaceutical
- Research
- Diagnostic
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Integrated DNA Technologies
- Agilent
- Sigma-aldrich
- Eurofins Genomics
- L.G.C Biosearch Technologies
- Eurogentec S.A
- Nitto Denko Avecia Inc
- GenScript
- BBI Life Sciences
- GeneDesign
- TriLink BioTechnologies
- SGS DNA
- LC Sciences
- Twist Bioscience
- Creative Biogene
- General Biosystems
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Oligonucleotides Market Size (2020-2031)
2.1.2 Oligonucleotides Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Oligonucleotides by Country/Region (2020, 2024 & 2031)
2.2 Oligonucleotides Segment by Type
2.2.1 DNA Oligos
2.2.2 RNA Oligos
2.3 Oligonucleotides Market Size by Type
2.3.1 Oligonucleotides Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Oligonucleotides Market Size Market Share by Type (2020-2025)
2.4 Oligonucleotides Segment by Application
2.4.1 Pharmaceutical
2.4.2 Research
2.4.3 Diagnostic
2.5 Oligonucleotides Market Size by Application
2.5.1 Oligonucleotides Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Oligonucleotides Market Size Market Share by Application (2020-2025)
3 OLIGONUCLEOTIDES MARKET SIZE BY PLAYER
3.1 Oligonucleotides Market Size Market Share by Player
3.1.1 Global Oligonucleotides Revenue by Player (2020-2025)
3.1.2 Global Oligonucleotides Revenue Market Share by Player (2020-2025)
3.2 Global Oligonucleotides Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 OLIGONUCLEOTIDES BY REGION
4.1 Oligonucleotides Market Size by Region (2020-2025)
4.2 Global Oligonucleotides Annual Revenue by Country/Region (2020-2025)
4.3 Americas Oligonucleotides Market Size Growth (2020-2025)
4.4 APAC Oligonucleotides Market Size Growth (2020-2025)
4.5 Europe Oligonucleotides Market Size Growth (2020-2025)
4.6 Middle East & Africa Oligonucleotides Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Oligonucleotides Market Size by Country (2020-2025)
5.2 Americas Oligonucleotides Market Size by Type (2020-2025)
5.3 Americas Oligonucleotides Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Oligonucleotides Market Size by Region (2020-2025)
6.2 APAC Oligonucleotides Market Size by Type (2020-2025)
6.3 APAC Oligonucleotides Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Oligonucleotides Market Size by Country (2020-2025)
7.2 Europe Oligonucleotides Market Size by Type (2020-2025)
7.3 Europe Oligonucleotides Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Oligonucleotides by Region (2020-2025)
8.2 Middle East & Africa Oligonucleotides Market Size by Type (2020-2025)
8.3 Middle East & Africa Oligonucleotides Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL OLIGONUCLEOTIDES MARKET FORECAST
10.1 Global Oligonucleotides Forecast by Region (2026-2031)
10.1.1 Global Oligonucleotides Forecast by Region (2026-2031)
10.1.2 Americas Oligonucleotides Forecast
10.1.3 APAC Oligonucleotides Forecast
10.1.4 Europe Oligonucleotides Forecast
10.1.5 Middle East & Africa Oligonucleotides Forecast
10.2 Americas Oligonucleotides Forecast by Country (2026-2031)
10.2.1 United States Market Oligonucleotides Forecast
10.2.2 Canada Market Oligonucleotides Forecast
10.2.3 Mexico Market Oligonucleotides Forecast
10.2.4 Brazil Market Oligonucleotides Forecast
10.3 APAC Oligonucleotides Forecast by Region (2026-2031)
10.3.1 China Oligonucleotides Market Forecast
10.3.2 Japan Market Oligonucleotides Forecast
10.3.3 Korea Market Oligonucleotides Forecast
10.3.4 Southeast Asia Market Oligonucleotides Forecast
10.3.5 India Market Oligonucleotides Forecast
10.3.6 Australia Market Oligonucleotides Forecast
10.4 Europe Oligonucleotides Forecast by Country (2026-2031)
10.4.1 Germany Market Oligonucleotides Forecast
10.4.2 France Market Oligonucleotides Forecast
10.4.3 UK Market Oligonucleotides Forecast
10.4.4 Italy Market Oligonucleotides Forecast
10.4.5 Russia Market Oligonucleotides Forecast
10.5 Middle East & Africa Oligonucleotides Forecast by Region (2026-2031)
10.5.1 Egypt Market Oligonucleotides Forecast
10.5.2 South Africa Market Oligonucleotides Forecast
10.5.3 Israel Market Oligonucleotides Forecast
10.5.4 Turkey Market Oligonucleotides Forecast
10.6 Global Oligonucleotides Forecast by Type (2026-2031)
10.7 Global Oligonucleotides Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Oligonucleotides Forecast
11 KEY PLAYERS ANALYSIS
11.1 Integrated DNA Technologies
11.1.1 Integrated DNA Technologies Company Information
11.1.2 Integrated DNA Technologies Oligonucleotides Product Offered
11.1.3 Integrated DNA Technologies Oligonucleotides Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Integrated DNA Technologies Main Business Overview
11.1.5 Integrated DNA Technologies Latest Developments
11.2 Agilent
11.2.1 Agilent Company Information
11.2.2 Agilent Oligonucleotides Product Offered
11.2.3 Agilent Oligonucleotides Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Agilent Main Business Overview
11.2.5 Agilent Latest Developments
11.3 Sigma-aldrich
11.3.1 Sigma-aldrich Company Information
11.3.2 Sigma-aldrich Oligonucleotides Product Offered
11.3.3 Sigma-aldrich Oligonucleotides Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Sigma-aldrich Main Business Overview
11.3.5 Sigma-aldrich Latest Developments
11.4 Eurofins Genomics
11.4.1 Eurofins Genomics Company Information
11.4.2 Eurofins Genomics Oligonucleotides Product Offered
11.4.3 Eurofins Genomics Oligonucleotides Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Eurofins Genomics Main Business Overview
11.4.5 Eurofins Genomics Latest Developments
11.5 L.G.C Biosearch Technologies
11.5.1 L.G.C Biosearch Technologies Company Information
11.5.2 L.G.C Biosearch Technologies Oligonucleotides Product Offered
11.5.3 L.G.C Biosearch Technologies Oligonucleotides Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 L.G.C Biosearch Technologies Main Business Overview
11.5.5 L.G.C Biosearch Technologies Latest Developments
11.6 Eurogentec S.A
11.6.1 Eurogentec S.A Company Information
11.6.2 Eurogentec S.A Oligonucleotides Product Offered
11.6.3 Eurogentec S.A Oligonucleotides Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Eurogentec S.A Main Business Overview
11.6.5 Eurogentec S.A Latest Developments
11.7 Nitto Denko Avecia Inc
11.7.1 Nitto Denko Avecia Inc Company Information
11.7.2 Nitto Denko Avecia Inc Oligonucleotides Product Offered
11.7.3 Nitto Denko Avecia Inc Oligonucleotides Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Nitto Denko Avecia Inc Main Business Overview
11.7.5 Nitto Denko Avecia Inc Latest Developments
11.8 GenScript
11.8.1 GenScript Company Information
11.8.2 GenScript Oligonucleotides Product Offered
11.8.3 GenScript Oligonucleotides Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 GenScript Main Business Overview
11.8.5 GenScript Latest Developments
11.9 BBI Life Sciences
11.9.1 BBI Life Sciences Company Information
11.9.2 BBI Life Sciences Oligonucleotides Product Offered
11.9.3 BBI Life Sciences Oligonucleotides Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 BBI Life Sciences Main Business Overview
11.9.5 BBI Life Sciences Latest Developments
11.10 GeneDesign
11.10.1 GeneDesign Company Information
11.10.2 GeneDesign Oligonucleotides Product Offered
11.10.3 GeneDesign Oligonucleotides Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 GeneDesign Main Business Overview
11.10.5 GeneDesign Latest Developments
11.11 TriLink BioTechnologies
11.11.1 TriLink BioTechnologies Company Information
11.11.2 TriLink BioTechnologies Oligonucleotides Product Offered
11.11.3 TriLink BioTechnologies Oligonucleotides Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 TriLink BioTechnologies Main Business Overview
11.11.5 TriLink BioTechnologies Latest Developments
11.12 SGS DNA
11.12.1 SGS DNA Company Information
11.12.2 SGS DNA Oligonucleotides Product Offered
11.12.3 SGS DNA Oligonucleotides Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 SGS DNA Main Business Overview
11.12.5 SGS DNA Latest Developments
11.13 LC Sciences
11.13.1 LC Sciences Company Information
11.13.2 LC Sciences Oligonucleotides Product Offered
11.13.3 LC Sciences Oligonucleotides Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 LC Sciences Main Business Overview
11.13.5 LC Sciences Latest Developments
11.14 Twist Bioscience
11.14.1 Twist Bioscience Company Information
11.14.2 Twist Bioscience Oligonucleotides Product Offered
11.14.3 Twist Bioscience Oligonucleotides Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Twist Bioscience Main Business Overview
11.14.5 Twist Bioscience Latest Developments
11.15 Creative Biogene
11.15.1 Creative Biogene Company Information
11.15.2 Creative Biogene Oligonucleotides Product Offered
11.15.3 Creative Biogene Oligonucleotides Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 Creative Biogene Main Business Overview
11.15.5 Creative Biogene Latest Developments
11.16 General Biosystems
11.16.1 General Biosystems Company Information
11.16.2 General Biosystems Oligonucleotides Product Offered
11.16.3 General Biosystems Oligonucleotides Revenue, Gross Margin and Market Share (2020-2025)
11.16.4 General Biosystems Main Business Overview
11.16.5 General Biosystems Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Oligonucleotides Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Oligonucleotides Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of DNA Oligos
Table 4. Major Players of RNA Oligos
Table 5. Oligonucleotides Market Size CAGR byType (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global Oligonucleotides Market Size byType (2020-2025) & ($ millions)
Table 7. Global Oligonucleotides Market Size Market Share byType (2020-2025)
Table 8. Oligonucleotides Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Oligonucleotides Market Size by Application (2020-2025) & ($ millions)
Table 10. Global Oligonucleotides Market Size Market Share by Application (2020-2025)
Table 11. Global Oligonucleotides Revenue by Player (2020-2025) & ($ millions)
Table 12. Global Oligonucleotides Revenue Market Share by Player (2020-2025)
Table 13. Oligonucleotides Key Players Head office and Products Offered
Table 14. Oligonucleotides Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Oligonucleotides Market Size by Region (2020-2025) & ($ millions)
Table 18. Global Oligonucleotides Market Size Market Share by Region (2020-2025)
Table 19. Global Oligonucleotides Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global Oligonucleotides Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas Oligonucleotides Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas Oligonucleotides Market Size Market Share by Country (2020-2025)
Table 23. Americas Oligonucleotides Market Size byType (2020-2025) & ($ millions)
Table 24. Americas Oligonucleotides Market Size Market Share byType (2020-2025)
Table 25. Americas Oligonucleotides Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas Oligonucleotides Market Size Market Share by Application (2020-2025)
Table 27. APAC Oligonucleotides Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC Oligonucleotides Market Size Market Share by Region (2020-2025)
Table 29. APAC Oligonucleotides Market Size byType (2020-2025) & ($ millions)
Table 30. APAC Oligonucleotides Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe Oligonucleotides Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe Oligonucleotides Market Size Market Share by Country (2020-2025)
Table 33. Europe Oligonucleotides Market Size byType (2020-2025) & ($ millions)
Table 34. Europe Oligonucleotides Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa Oligonucleotides Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa Oligonucleotides Market Size byType (2020-2025) & ($ millions)
Table 37. Middle East & Africa Oligonucleotides Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Oligonucleotides
Table 39. Key Market Challenges & Risks of Oligonucleotides
Table 40. Key IndustryTrends of Oligonucleotides
Table 41. Global Oligonucleotides Market SizeForecast by Region (2026-2031) & ($ millions)
Table 42. Global Oligonucleotides Market Size Market ShareForecast by Region (2026-2031)
Table 43. Global Oligonucleotides Market SizeForecast byType (2026-2031) & ($ millions)
Table 44. Global Oligonucleotides Market SizeForecast by Application (2026-2031) & ($ millions)
Table 45. Integrated DNATechnologies Details, CompanyType, Oligonucleotides Area Served and Its Competitors
Table 46. Integrated DNATechnologies Oligonucleotides Product Offered
Table 47. Integrated DNATechnologies Oligonucleotides Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. Integrated DNATechnologies Main Business
Table 49. Integrated DNATechnologies Latest Developments
Table 50. Agilent Details, CompanyType, Oligonucleotides Area Served and Its Competitors
Table 51. Agilent Oligonucleotides Product Offered
Table 52. Agilent Oligonucleotides Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. Agilent Main Business
Table 54. Agilent Latest Developments
Table 55. Sigma-aldrich Details, CompanyType, Oligonucleotides Area Served and Its Competitors
Table 56. Sigma-aldrich Oligonucleotides Product Offered
Table 57. Sigma-aldrich Oligonucleotides Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. Sigma-aldrich Main Business
Table 59. Sigma-aldrich Latest Developments
Table 60. Eurofins Genomics Details, CompanyType, Oligonucleotides Area Served and Its Competitors
Table 61. Eurofins Genomics Oligonucleotides Product Offered
Table 62. Eurofins Genomics Oligonucleotides Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. Eurofins Genomics Main Business
Table 64. Eurofins Genomics Latest Developments
Table 65. L.G.C BiosearchTechnologies Details, CompanyType, Oligonucleotides Area Served and Its Competitors
Table 66. L.G.C BiosearchTechnologies Oligonucleotides Product Offered
Table 67. L.G.C BiosearchTechnologies Oligonucleotides Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. L.G.C BiosearchTechnologies Main Business
Table 69. L.G.C BiosearchTechnologies Latest Developments
Table 70. Eurogentec S.A Details, CompanyType, Oligonucleotides Area Served and Its Competitors
Table 71. Eurogentec S.A Oligonucleotides Product Offered
Table 72. Eurogentec S.A Oligonucleotides Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 73. Eurogentec S.A Main Business
Table 74. Eurogentec S.A Latest Developments
Table 75. Nitto Denko Avecia Inc Details, CompanyType, Oligonucleotides Area Served and Its Competitors
Table 76. Nitto Denko Avecia Inc Oligonucleotides Product Offered
Table 77. Nitto Denko Avecia Inc Oligonucleotides Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 78. Nitto Denko Avecia Inc Main Business
Table 79. Nitto Denko Avecia Inc Latest Developments
Table 80. GenScript Details, CompanyType, Oligonucleotides Area Served and Its Competitors
Table 81. GenScript Oligonucleotides Product Offered
Table 82. GenScript Oligonucleotides Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 83. GenScript Main Business
Table 84. GenScript Latest Developments
Table 85. BBI Life Sciences Details, CompanyType, Oligonucleotides Area Served and Its Competitors
Table 86. BBI Life Sciences Oligonucleotides Product Offered
Table 87. BBI Life Sciences Oligonucleotides Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 88. BBI Life Sciences Main Business
Table 89. BBI Life Sciences Latest Developments
Table 90. GeneDesign Details, CompanyType, Oligonucleotides Area Served and Its Competitors
Table 91. GeneDesign Oligonucleotides Product Offered
Table 92. GeneDesign Oligonucleotides Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 93. GeneDesign Main Business
Table 94. GeneDesign Latest Developments
Table 95.TriLink BioTechnologies Details, CompanyType, Oligonucleotides Area Served and Its Competitors
Table 96.TriLink BioTechnologies Oligonucleotides Product Offered
Table 97.TriLink BioTechnologies Oligonucleotides Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 98.TriLink BioTechnologies Main Business
Table 99.TriLink BioTechnologies Latest Developments
Table 100. SGS DNA Details, CompanyType, Oligonucleotides Area Served and Its Competitors
Table 101. SGS DNA Oligonucleotides Product Offered
Table 102. SGS DNA Oligonucleotides Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 103. SGS DNA Main Business
Table 104. SGS DNA Latest Developments
Table 105. LC Sciences Details, CompanyType, Oligonucleotides Area Served and Its Competitors
Table 106. LC Sciences Oligonucleotides Product Offered
Table 107. LC Sciences Oligonucleotides Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 108. LC Sciences Main Business
Table 109. LC Sciences Latest Developments
Table 110.Twist Bioscience Details, CompanyType, Oligonucleotides Area Served and Its Competitors
Table 111.Twist Bioscience Oligonucleotides Product Offered
Table 112.Twist Bioscience Oligonucleotides Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 113.Twist Bioscience Main Business
Table 114.Twist Bioscience Latest Developments
Table 115. Creative Biogene Details, CompanyType, Oligonucleotides Area Served and Its Competitors
Table 116. Creative Biogene Oligonucleotides Product Offered
Table 117. Creative Biogene Oligonucleotides Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 118. Creative Biogene Main Business
Table 119. Creative Biogene Latest Developments
Table 120. General Biosystems Details, CompanyType, Oligonucleotides Area Served and Its Competitors
Table 121. General Biosystems Oligonucleotides Product Offered
Table 122. General Biosystems Oligonucleotides Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 123. General Biosystems Main Business
Table 124. General Biosystems Latest Developments
LIST OFFIGURES
Figure 1. Oligonucleotides Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Oligonucleotides Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Oligonucleotides Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Oligonucleotides Sales Market Share by Country/Region (2024)
Figure 8. Oligonucleotides Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Oligonucleotides Market Size Market Share byType in 2024
Figure 10. Oligonucleotides in Pharmaceutical
Figure 11. Global Oligonucleotides Market: Pharmaceutical (2020-2025) & ($ millions)
Figure 12. Oligonucleotides in Research
Figure 13. Global Oligonucleotides Market: Research (2020-2025) & ($ millions)
Figure 14. Oligonucleotides in Diagnostic
Figure 15. Global Oligonucleotides Market: Diagnostic (2020-2025) & ($ millions)
Figure 16. Global Oligonucleotides Market Size Market Share by Application in 2024
Figure 17. Global Oligonucleotides Revenue Market Share by Player in 2024
Figure 18. Global Oligonucleotides Market Size Market Share by Region (2020-2025)
Figure 19. Americas Oligonucleotides Market Size 2020-2025 ($ millions)
Figure 20. APAC Oligonucleotides Market Size 2020-2025 ($ millions)
Figure 21. Europe Oligonucleotides Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Oligonucleotides Market Size 2020-2025 ($ millions)
Figure 23. Americas Oligonucleotides Value Market Share by Country in 2024
Figure 24. United States Oligonucleotides Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Oligonucleotides Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Oligonucleotides Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Oligonucleotides Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Oligonucleotides Market Size Market Share by Region in 2024
Figure 29. APAC Oligonucleotides Market Size Market Share byType (2020-2025)
Figure 30. APAC Oligonucleotides Market Size Market Share by Application (2020-2025)
Figure 31. China Oligonucleotides Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Oligonucleotides Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Oligonucleotides Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Oligonucleotides Market Size Growth 2020-2025 ($ millions)
Figure 35. India Oligonucleotides Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Oligonucleotides Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Oligonucleotides Market Size Market Share by Country in 2024
Figure 38. Europe Oligonucleotides Market Size Market Share byType (2020-2025)
Figure 39. Europe Oligonucleotides Market Size Market Share by Application (2020-2025)
Figure 40. Germany Oligonucleotides Market Size Growth 2020-2025 ($ millions)
Figure 41.France Oligonucleotides Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Oligonucleotides Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Oligonucleotides Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Oligonucleotides Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Oligonucleotides Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Oligonucleotides Market Size Market Share byType (2020-2025)
Figure 47. Middle East & Africa Oligonucleotides Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Oligonucleotides Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Oligonucleotides Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Oligonucleotides Market Size Growth 2020-2025 ($ millions)
Figure 51.Turkey Oligonucleotides Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Oligonucleotides Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Oligonucleotides Market Size 2026-2031 ($ millions)
Figure 54. APAC Oligonucleotides Market Size 2026-2031 ($ millions)
Figure 55. Europe Oligonucleotides Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Oligonucleotides Market Size 2026-2031 ($ millions)
Figure 57. United States Oligonucleotides Market Size 2026-2031 ($ millions)
Figure 58. Canada Oligonucleotides Market Size 2026-2031 ($ millions)
Figure 59. Mexico Oligonucleotides Market Size 2026-2031 ($ millions)
Figure 60. Brazil Oligonucleotides Market Size 2026-2031 ($ millions)
Figure 61. China Oligonucleotides Market Size 2026-2031 ($ millions)
Figure 62. Japan Oligonucleotides Market Size 2026-2031 ($ millions)
Figure 63. Korea Oligonucleotides Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Oligonucleotides Market Size 2026-2031 ($ millions)
Figure 65. India Oligonucleotides Market Size 2026-2031 ($ millions)
Figure 66. Australia Oligonucleotides Market Size 2026-2031 ($ millions)
Figure 67. Germany Oligonucleotides Market Size 2026-2031 ($ millions)
Figure 68.France Oligonucleotides Market Size 2026-2031 ($ millions)
Figure 69. UK Oligonucleotides Market Size 2026-2031 ($ millions)
Figure 70. Italy Oligonucleotides Market Size 2026-2031 ($ millions)
Figure 71. Russia Oligonucleotides Market Size 2026-2031 ($ millions)
Figure 72. Egypt Oligonucleotides Market Size 2026-2031 ($ millions)
Figure 73. South Africa Oligonucleotides Market Size 2026-2031 ($ millions)
Figure 74. Israel Oligonucleotides Market Size 2026-2031 ($ millions)
Figure 75.Turkey Oligonucleotides Market Size 2026-2031 ($ millions)
Figure 76. Global Oligonucleotides Market Size Market ShareForecast byType (2026-2031)
Figure 77. Global Oligonucleotides Market Size Market ShareForecast by Application (2026-2031)
Figure 78. GCC Countries Oligonucleotides Market Size 2026-2031 ($ millions)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Oligonucleotides Market Size (2020-2031)
2.1.2 Oligonucleotides Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Oligonucleotides by Country/Region (2020, 2024 & 2031)
2.2 Oligonucleotides Segment by Type
2.2.1 DNA Oligos
2.2.2 RNA Oligos
2.3 Oligonucleotides Market Size by Type
2.3.1 Oligonucleotides Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Oligonucleotides Market Size Market Share by Type (2020-2025)
2.4 Oligonucleotides Segment by Application
2.4.1 Pharmaceutical
2.4.2 Research
2.4.3 Diagnostic
2.5 Oligonucleotides Market Size by Application
2.5.1 Oligonucleotides Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Oligonucleotides Market Size Market Share by Application (2020-2025)
3 OLIGONUCLEOTIDES MARKET SIZE BY PLAYER
3.1 Oligonucleotides Market Size Market Share by Player
3.1.1 Global Oligonucleotides Revenue by Player (2020-2025)
3.1.2 Global Oligonucleotides Revenue Market Share by Player (2020-2025)
3.2 Global Oligonucleotides Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 OLIGONUCLEOTIDES BY REGION
4.1 Oligonucleotides Market Size by Region (2020-2025)
4.2 Global Oligonucleotides Annual Revenue by Country/Region (2020-2025)
4.3 Americas Oligonucleotides Market Size Growth (2020-2025)
4.4 APAC Oligonucleotides Market Size Growth (2020-2025)
4.5 Europe Oligonucleotides Market Size Growth (2020-2025)
4.6 Middle East & Africa Oligonucleotides Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Oligonucleotides Market Size by Country (2020-2025)
5.2 Americas Oligonucleotides Market Size by Type (2020-2025)
5.3 Americas Oligonucleotides Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Oligonucleotides Market Size by Region (2020-2025)
6.2 APAC Oligonucleotides Market Size by Type (2020-2025)
6.3 APAC Oligonucleotides Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Oligonucleotides Market Size by Country (2020-2025)
7.2 Europe Oligonucleotides Market Size by Type (2020-2025)
7.3 Europe Oligonucleotides Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Oligonucleotides by Region (2020-2025)
8.2 Middle East & Africa Oligonucleotides Market Size by Type (2020-2025)
8.3 Middle East & Africa Oligonucleotides Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL OLIGONUCLEOTIDES MARKET FORECAST
10.1 Global Oligonucleotides Forecast by Region (2026-2031)
10.1.1 Global Oligonucleotides Forecast by Region (2026-2031)
10.1.2 Americas Oligonucleotides Forecast
10.1.3 APAC Oligonucleotides Forecast
10.1.4 Europe Oligonucleotides Forecast
10.1.5 Middle East & Africa Oligonucleotides Forecast
10.2 Americas Oligonucleotides Forecast by Country (2026-2031)
10.2.1 United States Market Oligonucleotides Forecast
10.2.2 Canada Market Oligonucleotides Forecast
10.2.3 Mexico Market Oligonucleotides Forecast
10.2.4 Brazil Market Oligonucleotides Forecast
10.3 APAC Oligonucleotides Forecast by Region (2026-2031)
10.3.1 China Oligonucleotides Market Forecast
10.3.2 Japan Market Oligonucleotides Forecast
10.3.3 Korea Market Oligonucleotides Forecast
10.3.4 Southeast Asia Market Oligonucleotides Forecast
10.3.5 India Market Oligonucleotides Forecast
10.3.6 Australia Market Oligonucleotides Forecast
10.4 Europe Oligonucleotides Forecast by Country (2026-2031)
10.4.1 Germany Market Oligonucleotides Forecast
10.4.2 France Market Oligonucleotides Forecast
10.4.3 UK Market Oligonucleotides Forecast
10.4.4 Italy Market Oligonucleotides Forecast
10.4.5 Russia Market Oligonucleotides Forecast
10.5 Middle East & Africa Oligonucleotides Forecast by Region (2026-2031)
10.5.1 Egypt Market Oligonucleotides Forecast
10.5.2 South Africa Market Oligonucleotides Forecast
10.5.3 Israel Market Oligonucleotides Forecast
10.5.4 Turkey Market Oligonucleotides Forecast
10.6 Global Oligonucleotides Forecast by Type (2026-2031)
10.7 Global Oligonucleotides Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Oligonucleotides Forecast
11 KEY PLAYERS ANALYSIS
11.1 Integrated DNA Technologies
11.1.1 Integrated DNA Technologies Company Information
11.1.2 Integrated DNA Technologies Oligonucleotides Product Offered
11.1.3 Integrated DNA Technologies Oligonucleotides Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Integrated DNA Technologies Main Business Overview
11.1.5 Integrated DNA Technologies Latest Developments
11.2 Agilent
11.2.1 Agilent Company Information
11.2.2 Agilent Oligonucleotides Product Offered
11.2.3 Agilent Oligonucleotides Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Agilent Main Business Overview
11.2.5 Agilent Latest Developments
11.3 Sigma-aldrich
11.3.1 Sigma-aldrich Company Information
11.3.2 Sigma-aldrich Oligonucleotides Product Offered
11.3.3 Sigma-aldrich Oligonucleotides Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Sigma-aldrich Main Business Overview
11.3.5 Sigma-aldrich Latest Developments
11.4 Eurofins Genomics
11.4.1 Eurofins Genomics Company Information
11.4.2 Eurofins Genomics Oligonucleotides Product Offered
11.4.3 Eurofins Genomics Oligonucleotides Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Eurofins Genomics Main Business Overview
11.4.5 Eurofins Genomics Latest Developments
11.5 L.G.C Biosearch Technologies
11.5.1 L.G.C Biosearch Technologies Company Information
11.5.2 L.G.C Biosearch Technologies Oligonucleotides Product Offered
11.5.3 L.G.C Biosearch Technologies Oligonucleotides Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 L.G.C Biosearch Technologies Main Business Overview
11.5.5 L.G.C Biosearch Technologies Latest Developments
11.6 Eurogentec S.A
11.6.1 Eurogentec S.A Company Information
11.6.2 Eurogentec S.A Oligonucleotides Product Offered
11.6.3 Eurogentec S.A Oligonucleotides Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Eurogentec S.A Main Business Overview
11.6.5 Eurogentec S.A Latest Developments
11.7 Nitto Denko Avecia Inc
11.7.1 Nitto Denko Avecia Inc Company Information
11.7.2 Nitto Denko Avecia Inc Oligonucleotides Product Offered
11.7.3 Nitto Denko Avecia Inc Oligonucleotides Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Nitto Denko Avecia Inc Main Business Overview
11.7.5 Nitto Denko Avecia Inc Latest Developments
11.8 GenScript
11.8.1 GenScript Company Information
11.8.2 GenScript Oligonucleotides Product Offered
11.8.3 GenScript Oligonucleotides Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 GenScript Main Business Overview
11.8.5 GenScript Latest Developments
11.9 BBI Life Sciences
11.9.1 BBI Life Sciences Company Information
11.9.2 BBI Life Sciences Oligonucleotides Product Offered
11.9.3 BBI Life Sciences Oligonucleotides Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 BBI Life Sciences Main Business Overview
11.9.5 BBI Life Sciences Latest Developments
11.10 GeneDesign
11.10.1 GeneDesign Company Information
11.10.2 GeneDesign Oligonucleotides Product Offered
11.10.3 GeneDesign Oligonucleotides Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 GeneDesign Main Business Overview
11.10.5 GeneDesign Latest Developments
11.11 TriLink BioTechnologies
11.11.1 TriLink BioTechnologies Company Information
11.11.2 TriLink BioTechnologies Oligonucleotides Product Offered
11.11.3 TriLink BioTechnologies Oligonucleotides Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 TriLink BioTechnologies Main Business Overview
11.11.5 TriLink BioTechnologies Latest Developments
11.12 SGS DNA
11.12.1 SGS DNA Company Information
11.12.2 SGS DNA Oligonucleotides Product Offered
11.12.3 SGS DNA Oligonucleotides Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 SGS DNA Main Business Overview
11.12.5 SGS DNA Latest Developments
11.13 LC Sciences
11.13.1 LC Sciences Company Information
11.13.2 LC Sciences Oligonucleotides Product Offered
11.13.3 LC Sciences Oligonucleotides Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 LC Sciences Main Business Overview
11.13.5 LC Sciences Latest Developments
11.14 Twist Bioscience
11.14.1 Twist Bioscience Company Information
11.14.2 Twist Bioscience Oligonucleotides Product Offered
11.14.3 Twist Bioscience Oligonucleotides Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Twist Bioscience Main Business Overview
11.14.5 Twist Bioscience Latest Developments
11.15 Creative Biogene
11.15.1 Creative Biogene Company Information
11.15.2 Creative Biogene Oligonucleotides Product Offered
11.15.3 Creative Biogene Oligonucleotides Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 Creative Biogene Main Business Overview
11.15.5 Creative Biogene Latest Developments
11.16 General Biosystems
11.16.1 General Biosystems Company Information
11.16.2 General Biosystems Oligonucleotides Product Offered
11.16.3 General Biosystems Oligonucleotides Revenue, Gross Margin and Market Share (2020-2025)
11.16.4 General Biosystems Main Business Overview
11.16.5 General Biosystems Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Oligonucleotides Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Oligonucleotides Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of DNA Oligos
Table 4. Major Players of RNA Oligos
Table 5. Oligonucleotides Market Size CAGR byType (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global Oligonucleotides Market Size byType (2020-2025) & ($ millions)
Table 7. Global Oligonucleotides Market Size Market Share byType (2020-2025)
Table 8. Oligonucleotides Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Oligonucleotides Market Size by Application (2020-2025) & ($ millions)
Table 10. Global Oligonucleotides Market Size Market Share by Application (2020-2025)
Table 11. Global Oligonucleotides Revenue by Player (2020-2025) & ($ millions)
Table 12. Global Oligonucleotides Revenue Market Share by Player (2020-2025)
Table 13. Oligonucleotides Key Players Head office and Products Offered
Table 14. Oligonucleotides Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Oligonucleotides Market Size by Region (2020-2025) & ($ millions)
Table 18. Global Oligonucleotides Market Size Market Share by Region (2020-2025)
Table 19. Global Oligonucleotides Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global Oligonucleotides Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas Oligonucleotides Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas Oligonucleotides Market Size Market Share by Country (2020-2025)
Table 23. Americas Oligonucleotides Market Size byType (2020-2025) & ($ millions)
Table 24. Americas Oligonucleotides Market Size Market Share byType (2020-2025)
Table 25. Americas Oligonucleotides Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas Oligonucleotides Market Size Market Share by Application (2020-2025)
Table 27. APAC Oligonucleotides Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC Oligonucleotides Market Size Market Share by Region (2020-2025)
Table 29. APAC Oligonucleotides Market Size byType (2020-2025) & ($ millions)
Table 30. APAC Oligonucleotides Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe Oligonucleotides Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe Oligonucleotides Market Size Market Share by Country (2020-2025)
Table 33. Europe Oligonucleotides Market Size byType (2020-2025) & ($ millions)
Table 34. Europe Oligonucleotides Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa Oligonucleotides Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa Oligonucleotides Market Size byType (2020-2025) & ($ millions)
Table 37. Middle East & Africa Oligonucleotides Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Oligonucleotides
Table 39. Key Market Challenges & Risks of Oligonucleotides
Table 40. Key IndustryTrends of Oligonucleotides
Table 41. Global Oligonucleotides Market SizeForecast by Region (2026-2031) & ($ millions)
Table 42. Global Oligonucleotides Market Size Market ShareForecast by Region (2026-2031)
Table 43. Global Oligonucleotides Market SizeForecast byType (2026-2031) & ($ millions)
Table 44. Global Oligonucleotides Market SizeForecast by Application (2026-2031) & ($ millions)
Table 45. Integrated DNATechnologies Details, CompanyType, Oligonucleotides Area Served and Its Competitors
Table 46. Integrated DNATechnologies Oligonucleotides Product Offered
Table 47. Integrated DNATechnologies Oligonucleotides Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. Integrated DNATechnologies Main Business
Table 49. Integrated DNATechnologies Latest Developments
Table 50. Agilent Details, CompanyType, Oligonucleotides Area Served and Its Competitors
Table 51. Agilent Oligonucleotides Product Offered
Table 52. Agilent Oligonucleotides Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. Agilent Main Business
Table 54. Agilent Latest Developments
Table 55. Sigma-aldrich Details, CompanyType, Oligonucleotides Area Served and Its Competitors
Table 56. Sigma-aldrich Oligonucleotides Product Offered
Table 57. Sigma-aldrich Oligonucleotides Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. Sigma-aldrich Main Business
Table 59. Sigma-aldrich Latest Developments
Table 60. Eurofins Genomics Details, CompanyType, Oligonucleotides Area Served and Its Competitors
Table 61. Eurofins Genomics Oligonucleotides Product Offered
Table 62. Eurofins Genomics Oligonucleotides Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. Eurofins Genomics Main Business
Table 64. Eurofins Genomics Latest Developments
Table 65. L.G.C BiosearchTechnologies Details, CompanyType, Oligonucleotides Area Served and Its Competitors
Table 66. L.G.C BiosearchTechnologies Oligonucleotides Product Offered
Table 67. L.G.C BiosearchTechnologies Oligonucleotides Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. L.G.C BiosearchTechnologies Main Business
Table 69. L.G.C BiosearchTechnologies Latest Developments
Table 70. Eurogentec S.A Details, CompanyType, Oligonucleotides Area Served and Its Competitors
Table 71. Eurogentec S.A Oligonucleotides Product Offered
Table 72. Eurogentec S.A Oligonucleotides Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 73. Eurogentec S.A Main Business
Table 74. Eurogentec S.A Latest Developments
Table 75. Nitto Denko Avecia Inc Details, CompanyType, Oligonucleotides Area Served and Its Competitors
Table 76. Nitto Denko Avecia Inc Oligonucleotides Product Offered
Table 77. Nitto Denko Avecia Inc Oligonucleotides Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 78. Nitto Denko Avecia Inc Main Business
Table 79. Nitto Denko Avecia Inc Latest Developments
Table 80. GenScript Details, CompanyType, Oligonucleotides Area Served and Its Competitors
Table 81. GenScript Oligonucleotides Product Offered
Table 82. GenScript Oligonucleotides Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 83. GenScript Main Business
Table 84. GenScript Latest Developments
Table 85. BBI Life Sciences Details, CompanyType, Oligonucleotides Area Served and Its Competitors
Table 86. BBI Life Sciences Oligonucleotides Product Offered
Table 87. BBI Life Sciences Oligonucleotides Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 88. BBI Life Sciences Main Business
Table 89. BBI Life Sciences Latest Developments
Table 90. GeneDesign Details, CompanyType, Oligonucleotides Area Served and Its Competitors
Table 91. GeneDesign Oligonucleotides Product Offered
Table 92. GeneDesign Oligonucleotides Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 93. GeneDesign Main Business
Table 94. GeneDesign Latest Developments
Table 95.TriLink BioTechnologies Details, CompanyType, Oligonucleotides Area Served and Its Competitors
Table 96.TriLink BioTechnologies Oligonucleotides Product Offered
Table 97.TriLink BioTechnologies Oligonucleotides Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 98.TriLink BioTechnologies Main Business
Table 99.TriLink BioTechnologies Latest Developments
Table 100. SGS DNA Details, CompanyType, Oligonucleotides Area Served and Its Competitors
Table 101. SGS DNA Oligonucleotides Product Offered
Table 102. SGS DNA Oligonucleotides Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 103. SGS DNA Main Business
Table 104. SGS DNA Latest Developments
Table 105. LC Sciences Details, CompanyType, Oligonucleotides Area Served and Its Competitors
Table 106. LC Sciences Oligonucleotides Product Offered
Table 107. LC Sciences Oligonucleotides Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 108. LC Sciences Main Business
Table 109. LC Sciences Latest Developments
Table 110.Twist Bioscience Details, CompanyType, Oligonucleotides Area Served and Its Competitors
Table 111.Twist Bioscience Oligonucleotides Product Offered
Table 112.Twist Bioscience Oligonucleotides Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 113.Twist Bioscience Main Business
Table 114.Twist Bioscience Latest Developments
Table 115. Creative Biogene Details, CompanyType, Oligonucleotides Area Served and Its Competitors
Table 116. Creative Biogene Oligonucleotides Product Offered
Table 117. Creative Biogene Oligonucleotides Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 118. Creative Biogene Main Business
Table 119. Creative Biogene Latest Developments
Table 120. General Biosystems Details, CompanyType, Oligonucleotides Area Served and Its Competitors
Table 121. General Biosystems Oligonucleotides Product Offered
Table 122. General Biosystems Oligonucleotides Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 123. General Biosystems Main Business
Table 124. General Biosystems Latest Developments
LIST OFFIGURES
Figure 1. Oligonucleotides Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Oligonucleotides Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Oligonucleotides Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Oligonucleotides Sales Market Share by Country/Region (2024)
Figure 8. Oligonucleotides Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Oligonucleotides Market Size Market Share byType in 2024
Figure 10. Oligonucleotides in Pharmaceutical
Figure 11. Global Oligonucleotides Market: Pharmaceutical (2020-2025) & ($ millions)
Figure 12. Oligonucleotides in Research
Figure 13. Global Oligonucleotides Market: Research (2020-2025) & ($ millions)
Figure 14. Oligonucleotides in Diagnostic
Figure 15. Global Oligonucleotides Market: Diagnostic (2020-2025) & ($ millions)
Figure 16. Global Oligonucleotides Market Size Market Share by Application in 2024
Figure 17. Global Oligonucleotides Revenue Market Share by Player in 2024
Figure 18. Global Oligonucleotides Market Size Market Share by Region (2020-2025)
Figure 19. Americas Oligonucleotides Market Size 2020-2025 ($ millions)
Figure 20. APAC Oligonucleotides Market Size 2020-2025 ($ millions)
Figure 21. Europe Oligonucleotides Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Oligonucleotides Market Size 2020-2025 ($ millions)
Figure 23. Americas Oligonucleotides Value Market Share by Country in 2024
Figure 24. United States Oligonucleotides Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Oligonucleotides Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Oligonucleotides Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Oligonucleotides Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Oligonucleotides Market Size Market Share by Region in 2024
Figure 29. APAC Oligonucleotides Market Size Market Share byType (2020-2025)
Figure 30. APAC Oligonucleotides Market Size Market Share by Application (2020-2025)
Figure 31. China Oligonucleotides Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Oligonucleotides Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Oligonucleotides Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Oligonucleotides Market Size Growth 2020-2025 ($ millions)
Figure 35. India Oligonucleotides Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Oligonucleotides Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Oligonucleotides Market Size Market Share by Country in 2024
Figure 38. Europe Oligonucleotides Market Size Market Share byType (2020-2025)
Figure 39. Europe Oligonucleotides Market Size Market Share by Application (2020-2025)
Figure 40. Germany Oligonucleotides Market Size Growth 2020-2025 ($ millions)
Figure 41.France Oligonucleotides Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Oligonucleotides Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Oligonucleotides Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Oligonucleotides Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Oligonucleotides Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Oligonucleotides Market Size Market Share byType (2020-2025)
Figure 47. Middle East & Africa Oligonucleotides Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Oligonucleotides Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Oligonucleotides Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Oligonucleotides Market Size Growth 2020-2025 ($ millions)
Figure 51.Turkey Oligonucleotides Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Oligonucleotides Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Oligonucleotides Market Size 2026-2031 ($ millions)
Figure 54. APAC Oligonucleotides Market Size 2026-2031 ($ millions)
Figure 55. Europe Oligonucleotides Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Oligonucleotides Market Size 2026-2031 ($ millions)
Figure 57. United States Oligonucleotides Market Size 2026-2031 ($ millions)
Figure 58. Canada Oligonucleotides Market Size 2026-2031 ($ millions)
Figure 59. Mexico Oligonucleotides Market Size 2026-2031 ($ millions)
Figure 60. Brazil Oligonucleotides Market Size 2026-2031 ($ millions)
Figure 61. China Oligonucleotides Market Size 2026-2031 ($ millions)
Figure 62. Japan Oligonucleotides Market Size 2026-2031 ($ millions)
Figure 63. Korea Oligonucleotides Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Oligonucleotides Market Size 2026-2031 ($ millions)
Figure 65. India Oligonucleotides Market Size 2026-2031 ($ millions)
Figure 66. Australia Oligonucleotides Market Size 2026-2031 ($ millions)
Figure 67. Germany Oligonucleotides Market Size 2026-2031 ($ millions)
Figure 68.France Oligonucleotides Market Size 2026-2031 ($ millions)
Figure 69. UK Oligonucleotides Market Size 2026-2031 ($ millions)
Figure 70. Italy Oligonucleotides Market Size 2026-2031 ($ millions)
Figure 71. Russia Oligonucleotides Market Size 2026-2031 ($ millions)
Figure 72. Egypt Oligonucleotides Market Size 2026-2031 ($ millions)
Figure 73. South Africa Oligonucleotides Market Size 2026-2031 ($ millions)
Figure 74. Israel Oligonucleotides Market Size 2026-2031 ($ millions)
Figure 75.Turkey Oligonucleotides Market Size 2026-2031 ($ millions)
Figure 76. Global Oligonucleotides Market Size Market ShareForecast byType (2026-2031)
Figure 77. Global Oligonucleotides Market Size Market ShareForecast by Application (2026-2031)
Figure 78. GCC Countries Oligonucleotides Market Size 2026-2031 ($ millions)
More Publications
Global Lipid-regulating Drugs Market Growth (Status and Outlook) 2023-2029
US$ 3,660.00
March 2023
89 pages
Global Silver Wound Management Dressing Market Growth 2023-2029
US$ 3,660.00
February 2023
114 pages
Global Rehabilitation Training Robotics Market Growth 2026-2032
US$ 3,660.00
July 2026
188 pages
Global First Aid Packaging Kit Market Growth 2023-2029
US$ 3,660.00
March 2023
115 pages
Global Closed System Drug Transfer Device (CSTD) Market Growth 2025-2031
US$ 3,660.00
March 2025
91 pages
